Halberd Co. (OTCMKTS:HALB) Short Interest Up ∞ in August

Halberd Co. (OTCMKTS:HALBGet Free Report) was the recipient of a large growth in short interest during the month of August. As of August 31st, there was short interest totaling 62,846 shares, a growth of ∞ from the August 15th total of 0 shares. Based on an average daily volume of 355,993 shares, the days-to-cover ratio is currently 0.2 days.

Halberd Price Performance

Shares of HALB stock opened at $0.00 on Thursday. Halberd has a 1-year low of $0.00 and a 1-year high of $0.00.

About Halberd

(Get Free Report)

Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.

Featured Stories

Receive News & Ratings for Halberd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Halberd and related companies with MarketBeat.com's FREE daily email newsletter.